About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Psoriatic Arthritis Treat to Target vs. Usual Care | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNNANCT01692912

Psoriatic Arthritis Treat to Target vs. Usual Care

Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score \<2.6), or as per their routine care. The aim of this study ...

Lead sponsor: Pope Research Corporation•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pope Research Corporation

Collaborators

Amgen

Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score \<2.6), or as per their routine care. The aim of this study is to determine whether treating to a target results in greater disease improvement than treating patients using routine care.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Psoriatic Arthritis as diagnosed by a rheumatologist and meeting ACR classification criteria for PsA or CASPAR criteria
•The subject must provide written informed consent for participation in the study before any study specific procedures are performed
•Subject has 3 or more SJC on 28 joint count
•Age \>=18

Exclusion Criteria

•Subject has a history of being non-compliant
•Serious concomitant illnesses that in the investigator's opinion negate ability to optimally treat the patient
•If treating with TNF inhibitor, positive PPD \> 5mm who have not received INH for recommended course or untreated TB (ie CXR evidence of latent infection). Usual screening is in place for standard of care.
•Pregnancy, breast-feeding or considering pregnancy over the next 12 months

Related studies

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more

RECRUITINGPhase 1

Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis

NCT06628206 · Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA)

Not Yet RecruitingNA

Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis

NCT07460739 · Rhumatoid Arthisis, Spondyloarthritis (SA), and more

Not Yet RecruitingNA

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

NCT07443956 · Psoriatic Arthritis (PsA), Obesity & Overweight

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 7, 2017Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateOct 2012

Last updatedApr 7, 2017

Condition

Psoriatic Arthritis (PsA)

Locations shown

Pope Research Corp., 68 Green Acres Drive

London, Ontario

The Arthritis Program Research Group

Newmarket, Ontario

Arthur Karasik

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 7, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions